Ozone oxidative preconditioning prevents atherosclerosis development in New Zealand white rabbits

Journal of Cardiovascular Pharmacology

Volumn 61, Issue 2, 2013, Pages 160-165

  Delgado Roche, Livan ^a   Martínez Sánchez, Gregorio ^b   Re, Lamberto ^b,c  

^a UNIVERSITY OF HAVANA   (Cuba)

^b Medinat srl   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

atherosclerosis; Lipofundin; oxidative stress; ozone

Indexed keywords

BIOLOGICAL MARKER; CATALASE; EOSIN; HEMATOXYLIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOFUNDIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OZONE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; ENZYME ACTIVITY; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; OZONE THERAPY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; AORTA; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; LIPIDS; MALE; OXIDATIVE STRESS; OXYGEN; OZONE; PHOSPHOLIPIDS; RABBITS; SORBITOL; SPECTROPHOTOMETRY;

EID: 84873409964     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31827a820d     Document Type: Article

References (42)

1. Tavori H, Aviram M, Khatib S, et al. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med. 2009;46:607-615.
2. Williams KJ, Tabas I. The response-to-retention hypothesis of atherogenesis reinforced. Curr Opin Lipidol. 1998;9:471-474.
3. Tabas I, Tall A, Accili D. The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circ Res. 2010;106:58-67.
4. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med. 2002;8:1211-1217.
5. Fubini B, Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med. 2003;34:1507-1516.
6. Ishii H, Kizaki K, Horie S, et al. Oxidized low density lipoprotein reduces thrombomodulin transcription in cultured human endothelial cells through degradation of the lipoprotein in lysosomes. J Biol Chem. 1996;271:8458-8465.
7. Jellinek H, Harsing J, Fuzesi S. A new model for arteriosclerosis. An electron-microscopic study of the lesions induced by i.v. administered fat. Atherosclerosis. 1982;43:7-18.
8. Delgado Roche L, Acosta Medina E, Fraga Perez A, et al. Lipofundininduced hyperlipidemia promotes oxidative stress and atherosclerotic lesions in new zealand white rabbits. Int J Vasc Med. 2012;2012:898769.
9. Re L, Malcangi G, Martinez-Sanchez G. Medical ozone is now ready for a scientific challenge: current status and future perspectives. J Exp Integr Med. 2012;2:193-196.
10. Hernandez F, Menendez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic Biol Med. 1995;19:115-119.
11. Delgado-Roche L, Martínez-Sánchez G, Díaz-Batista A, et al. Effects of ozone therapy on oxidative stress biomarkers in coronary artery disease patients. Int J Ozone Ther. 2011;10:99-104.
12. Noa M, Mas R, de la Rosa MC, et al. Effect of policosanol on lipofundininduced atherosclerotic lesions in rats. J Pharm Pharmacol. 1995;47: 289-291.
13. Ruengsakulrach P, Sinclair R, Komeda M, et al. Comparative histopathology of radial artery versus internal thoracic artery and risk factors for development of intimal hyperplasia and atherosclerosis. Circulation. 1999;100(19 suppl):II139-II144.
14. Strom A, Franzen A, Wangnerud C, et al. Altered vascular remodeling in osteopontin-deficient atherosclerotic mice. J Vasc Res. 2004;41:314-322.
15. Haining JL, Legan JS. Improved assay for catalase based upon steadystate substrate concentration. Anal Biochem. 1972;45:469-479.
16. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968; 25:192-205.
17. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161:2524-2532.
18. Erdelmeier I, Gerard-Monnier D, Yadan JC, et al. Reactions of N-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation. Chem Res Toxicol. 1998;11:1184-1194.
19. Ozdemirler G, Mehmetcik G, Oztezcan S, et al. Peroxidation potential and antioxidant activity of serum in patients with diabetes mellitus and myocard infarction. Horm Metab Res. 1995;27:194-196.
20. Marzinzig M, Nussler AK, Stadler J, et al. Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide. 1997;1:177-189.
21. Duner P, To F, Beckmann K, et al. Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis. Cardiovasc Res. 2011;91:528-536.
22. Haidari M, Ali M, Gangehei L, et al. Increased oxidative stress in atherosclerosis-predisposed regions of the mouse aorta. Life Sci. 2010;87:100-110.
23. Ajamieh HH, Menendez S, Martinez-Sanchez G, et al. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int. 2004; 24:55-62.
24. Ajamieh HH, Berlanga J, Merino N, et al. Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion. Transpl Int. 2005;18:604-612.
25. Candelario-Jalil E, Mohammed-Al-Dalain S, Fernandez OS, et al. Oxidative preconditioning affords protection against carbon tetrachlorideinduced glycogen depletion and oxidative stress in rats. J Appl Toxicol. 2001;21:297-301.
26. Levy Y, Blum S, Levy AP. Antioxidants in the prevention of atherosclerosis: The importance of proper patient selection. Clin Nutr. 2009;28:581-582.
27. Vogiatzi G, Tousoulis D, Stefanadis C. The role of oxidative stress in atherosclerosis. Hellenic J Cardiol. 2009;50:402-409.
28. Suh JH, Romain C, Gonzalez-Barrio R, et al. Raspberry juice consumption, oxidative stress and reduction of atherosclerosis risk factors in hypercholesterolemic golden Syrian hamsters. Food Funct. 2011;2:400-405.
29. Re L, Mawsouf MN, Menendez S, et al. Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res. 2008;39:17-26.
30. Martinez-Sanchez G, Al-Dalain SM, Menendez S, et al. Therapeutic efficacy of ozone in patients with diabetic foot. Eur J Pharmacol. 2005;523:151-161.
31. Martínez-Sánchez G, Al-Dalain SM, Menendéz S, et al. Ozone treatment reduces blood oxidative stress and pancreas damage in a streptozotocin-induced diabetes model in rats. Acta Farm Bonaerense. 2005;24: 491-497.
32. Martínez-Sánchez G, Delgado-Roche L, Díaz-Batista A, et al. Effects of ozone therapy on haemostatic and oxidative stress index in coronary artery disease. Eur J Pharmacol. 2012;691:156-162.
33. Mawsouf MN, El-Sawalhi MM, Darwish HA, et al. Effect of ozone therapy on redox status in experimentally induced arthritis. Rev Esp Ozonoterapia. 2011;1:32-43.
34. Morishita T, Uzui H, Nakano A, et al. Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase. J Atheroscler Thromb. 2012;19:149-158.
35. Malle E, Waeg G, Schreiber R, et al. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem. 2000;267:4495-4503.
36. Capeillere-Blandin C, Gausson V, Descamps-Latscha B, et al. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta. 2004;1689:91-102.
37. Grone HJ, Grone EF, Malle E. Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis. Lab Invest. 2002;82:5-14.
38. Zhao R, Shen GX. Functional modulation of antioxidant enzymes in vascular endothelial cells by glycated LDL. Atherosclerosis. 2005;179: 277-284.
39. León OS, Menéndez S, Merino N, et al. Ozone Oxidative preconditioning: A protection against cellular damage by free radicals. Mediators of Inflamm. 1998;7:298.
40. Circu ML, Aw TY. Glutathione and apoptosis. Free Radic Res. 2008;42: 689-706.
41. Forgione MA, Weiss N, Heydrick S, et al. Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2002;282:H1255-H1261.
42. Hayashi T, Yano K, Matsui-Hirai H, et al. Nitric oxide and endothelial cellular senescence. Pharmacol Ther. 2008;120:333-339.